‘One thing people often overlook is the adaptive immune response caused by vaccination is natural. Vaccination prepares the body’s immune system in the same way “natural” exposure to infection does. It just does it in a safer, controlled way with a much lower dose.
‘Given there’s no underlying reason why natural health and vaccination cannot coexist, why does this perception exist, and why does it persist?’
Read here (The Conversation, Oct 19, 2021)
‘SARS-CoV-2, the virus that causes COVID-19, can sometimes cause the immune system to mistakenly attack the person’s own body. This process, known as “autoimmunity”, can damage a number of different organs... The science on how and how often this occurs is still emerging. But here’s what we know so far...
This article attempts to answer the following:
Read here (The Conversation, Sept 23, 2021)
‘The increased prominence of antisemitic incidents during the COVID pandemic may leave you wondering: has antisemitism always been part of the Australian social fabric, or are we facing a new, sinister trend? Members of Melbourne’s Jewish community have been subjected to a surge of antisemitic abuse in recent weeks, following breaches of public health orders by ultra-Orthodox Jewish worshippers.
‘And Victoria’s proposed law to ban Nazi symbols — a first for any state or territory — further reinforces how antisemitism is becoming an increasingly visible problem in Australia.’
Read here (The Conversation, Sept 22, 2021)
‘Far right nationalists, anti-vaxxers, libertarians and conspiracy theorists have come together over COVID, and capitalised on the anger and uncertainty simmering in some sections of the community. They appear to have found fertile ground particularly among men who feel alienated, fearful about their employment and who spend a lot of time at home scrolling social media and encrypted messaging apps.’
Read here (The Conversation, Sept 21, 2021)
‘As the rollout of COVID-19 vaccines continues, public attention is increasingly turning to booster shots, which aim to top up immunity if it wanes. But is a third dose needed? And if so, when? Let’s take a look at what the data tell us so far about how long immunity from COVID-19 vaccines might last.
Read here (The Conversation, Aug 30, 2021)
‘Maintaining and promoting trust is important when it comes to vaccine mandates. It matters to people subject to mandates and it matters to the public more broadly because mutual trust is a cornerstone of effective public health engagement. People should feel supported in their health decision making and they should trust and feel respected by their employers. We’re seeing increasing politicisation about COVID public health measures, in Australia and internationally. This is a social harm we should avoid.’
Read here (The Conversation, August 18, 2021)
It is clear that there is now a humanitarian crisis of significant proportions. India is a country of 1.4 billion people and makes up a sixth of the world’s population. Here are some ways in which it is also going to affect the world economy:
Read here (The Conversation, Apr 29, 2021)
‘Put simply, the game has changed, and a successful global rollout of current vaccines by itself is no longer a guarantee of victory... No one is truly safe from COVID-19 until everyone is safe. We are in a race against time to get global transmission rates low enough to prevent the emergence and spread of new variants. The danger is that variants will arise that can overcome the immunity conferred by vaccinations or prior infection.
‘What’s more, many countries lack the capacity to track emerging variants via genomic surveillance. This means the situation may be even more serious than it appears.
‘As members of the Lancet COVID-19 Commission Taskforce on Public Health, we call for urgent action in response to the new variants. These new variants mean we cannot rely on the vaccines alone to provide protection but must maintain strong public health measures to reduce the risk from these variants. At the same time, we need to accelerate the vaccine program in all countries in an equitable way. Together, these strategies will deliver “maximum suppression” of the virus.’
Read here (The Conversation, Apr 6, 2021)
Download report here (Lancet Covid-19 Commission Taskforce on Public Health, March 2021)
‘As the COVID-19 pandemic disproportionately harms underprivileged people globally, Cuba’s “people over profit” approach has been saving many lives — both on the island and abroad. From the onset, Cuba’s approach has been holistic and integrated.
‘Its response is among the most respected in the world. Widespread confidence in the Cuban government’s science-based policies, public service media messaging and volunteerism are key reasons as to why Cuba has been able to control the viral reproduction rate until mass vaccination begins.
‘The cash-strapped Caribbean island risked opening to holiday visitors at the end of 2020 and is currently managing higher COVID-19 caseloads than ever before. Its health experts are combining international clinical trials of its vaccine candidates with mass production. Cuba is the only Latin American country with the capacity to manufacture a vaccine domestically other than Brazil, which is not doing so. Cuba aims to protect its populace, then give away or sell its vaccines abroad.’
Read here (The Conversation, Mar 17, 2021)
‘You may already know that viruses mutate, that this is normal and these small changes to the virus’s genetic code are to be expected. Well, that’s true, but that doesn’t mean they’re always harmless. Many mutations will be irrelevant, and some will make a virus weaker and will die out. But others will make it fitter, giving it an advantage over other variants and allowing it to out-compete them.
‘As people socially distance, observe stricter personal hygiene and wear masks, it becomes an advantage for the virus to be more transmissible. Similarly, as more people around the world gain immunity through being infected or vaccinated, another advantage would be for the virus to change so that antibodies can no longer attach to it and prevent it from infecting cells.
‘It’s therefore not surprising to see variants with mutations that provide these advantages now out-competing other forms of the coronavirus. Control measures and rising immunity are pressuring the coronavirus to evolve.’
Read here (The Conversation, Mar 3, 2021)
‘As part of the mission, we met the man who, on December 8, 2019, was the first confirmed COVID-19 case; he’s since recovered. We met the husband of a doctor who died of COVID-19 and left behind a young child. We met the doctors who worked in the Wuhan hospitals treating those early COVID-19 cases, and learned what happened to them and their colleagues. We witnessed the impact of COVID-19 on many individuals and communities, affected so early in the pandemic, when we didn’t know much about the virus, how it spreads, how to treat COVID-19, or its impacts.
‘We talked to our Chinese counterparts — scientists, epidemiologists, doctors — over the four weeks the WHO mission was in China. We were in meetings with them for up to 15 hours a day, so we became colleagues, even friends. This allowed us to build respect and trust in a way you couldn’t necessarily do via Zoom or email.
‘This is what we learned about the origins of SARS-CoV-2:
Read here (The Conversation, Feb 22, 2021)
‘With current vaccine shortages, and problems with setting up the infrastructure to vaccinate millions of people, many physicians are concerned that the second dose of vaccine won’t be delivered in the prescribed three-to-four-week window.
‘That booster shot is necessary for the T-cells to stimulate the memory B-cells to produce massive quantities of antibodies. If the booster isn’t given within the appropriate window, lower quantities of antibodies will be produced that may not provide as powerful protection from the virus.’
Read here (The Conversation, Jan 29, 2021)